Bottom line
How much do IXJ and GGHCX overlap?
51% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 39.4% of IXJ's assets and 41.9% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings IXJ and GGHCX have in common
| Holding | % of IXJ | % of GGHCX | Overlap |
|---|---|---|---|
| Eli Lilly And Company | 10.93% | 10.59% | 10.59% |
| Johnson & Johnson | 7.04% | 6.76% | 6.76% |
| Abbvie Inc. | 5.12% | 4.03% | 4.03% |
| Unitedhealth Group Incorporated | 4.40% | 6.17% | 4.40% |
| Merck & Co., Inc. | 4.12% | 4.59% | 4.12% |
| Thermo Fisher Scientific Incorporated | 2.42% | 1.55% | 1.55% |
| Gilead Sciences, Inc. | 2.04% | 3.63% | 2.04% |
| Cvs Health Corporation | 1.71% | 2.52% | 1.71% |
| Vertex Pharmaceuticals Incorporated | 1.64% | 2.01% | 1.64% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IXJ
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Abbott Laboratories — 2.05%
- Novo Nordisk A/s — 1.99%
- Intuitive Surgical, Inc. — 1.83%
- Pfizer Inc. — 1.78%
- Danaher Corporation — 1.56%
- Bristol-myers Squibb Company — 1.53%
- Stryker Corporation — 1.41%
- Gsk Plc — 1.38%
- Medtronic Public Limited Company — 1.30%
- Sanofi Sa — 1.18%
- Mckesson Corporation — 1.18%
Only in GGHCX
- Invesco Private Prime Fund — 4.67%
- argenx SE — 3.24%
- Welltower Inc. — 2.34%
- BrightSpring Health Services, Inc. — 2.20%
- Royalty Pharma PLC — 2.13%
- Cardinal Health, Inc. — 2.10%
- Guardant Health, Inc. — 2.04%
- Invesco Private Government Fund — 1.80%
- Axsome Therapeutics, Inc. — 1.58%
- Edwards Lifesciences Corp. — 1.56%
- Invesco Treasury Portfolio — 1.56%
- BridgeBio Pharma, Inc. — 1.43%
- Waters Corp. — 1.41%
- IQVIA Holdings Inc. — 1.32%
- U C B S.a. — 1.24%
Asset mix
| Asset type | IXJ | GGHCX |
|---|---|---|
| Stocks | 99.6% | 97.5% |
| Cash & short-term funds | 1.3% | 8.8% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | IXJ | GGHCX |
|---|---|---|
| US | 70.6% | 93.5% |
| CH | 10.4% | 2.7% |
| GB | 5.8% | 3.1% |
| JP | 3.7% | — |
| NL | 1.1% | 3.4% |
| DK | 2.3% | 1.1% |
| FR | 2.0% | — |
| DE | 1.6% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do IXJ and GGHCX overlap?
What stocks do IXJ and GGHCX have in common?
Should I own both IXJ and GGHCX?
Which holds more stocks, IXJ or GGHCX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.